Sequoia Capital India has invested $19.3 million in nine-year Sigmoid to date, according to a statement.

Sigmoid, a data engineering, analytics, and AI solutions company, has raised ₹12 million in a Series B round from Sequoia Capital India in a mix of primary and secondary funding.

In this select study population, long-term HAART was associated with complete CD4+ T-cell reconstitution in sigmoid colon. However, colonic immune activation may drive ongoing HIV replication.

Sequoia infuses additional $12 mn in data analytics startup Sigmoid The fresh capital is expected to drive Sigmoid's market offerings, expand delivery centres and cater to new industries.